Preclinical modeling and multimodality imaging of chronic myocardial infarction in minipigs induced by novel interventional embolization technique

Abstract

BackgroundThis study was designed to establish a chronic myocardial infarction (MI) model in minipigs with a novel coronary sequential balloons-sponge embolism technique.MethodsEighteen healthy minipigs (25–30 kg) were randomly divided into three groups for left anterior descending artery (LAD) occlusion: conventional balloon occlusion group (BO group, temporary balloon occlusion for 60 mins), half-balloon embolism group (HB group), and sequential balloon-balloon-sponge embolism group (BBS group, two half-balloons with one sponge as the embolism clot). The incidence of ventricular fibrillation (VF), total mortality, operating time, and vascular recanalization 3 months post-MI was recorded and compared. Echocardiography, multimodality nuclear medical imaging, and histology staining were applied for the evaluation of infarction.ResultsThirteen out of 18 minipigs survived after the operation, while 5 animals died with VF (3 in the BO group, 1 in the HB group, and 1 in the BBS group), with an 83.3 % (5/6 minipigs) acute procedural survival rate in embolism groups. The operating duration was 60.0 ± 0.5 mins, 21.4 ± 5.2 mins, and 31.2 ± 4.7 mins in the three groups, respectively. LAD recanalization was found in three animals of the HB group but none in the BBS group by angiography follow-up. The infarct sizes were more stable and larger in the HB group and BBS group than that in the BO group (P < 0.05, n = 13).ConclusionsThe method of sequential balloons-sponge embolization could induce myocardial infarction with consistent and sustained embolization and gain higher operation success rate and better repeatability in minipigs, which holds a promising method for preclinical MI study.Electronic supplementary materialThe online version of this article (doi:10.1186/s13550-016-0214-7) contains supplementary material, which is available to authorized users.

The Current Dilemma and Breakthrough of Stem Cell Therapy in Ischemic Heart Disease

“…The key to multimodal imaging is multifunctional contrast agents. In recent years, due to the rapid development of multifunctional contrast agents, many scholars have studied ultrasound (US)/MRI (Mahmoudi et al, 2015), US/MRI/fluorescence (Sung et al, 2009), US/CT/MRI (Tang et al, 2014), and other multimodal stem cell tracing modes (Tao et al, 2016;Li et al, 2017;Qiao et al, 2017;Su et al, 2017). For pre-clinical research, the more detail the better, while for clinical applications, the more convenient the better.…”

Neuroprotective effects of Morinda officinalis How.: Anti-inflammatory and antioxidant roles in Alzheimer’s disease

“…Furthermore, asperulosidic acid blocks polycoagulamine-induced erythrocyte aggregation and thrombin activity ( Murata et al, 2014 ), suggesting that asperulosidic acid may have clinical applications in improving blood fluidity and could represent a novel therapeutic strategy for the prevention and treatment of thrombotic diseases. In terms of antitumor effects, citrifolinoside and citrifolinin A significantly inhibit the activity of ultraviolet-induced active protein 1, which plays an important role in tumor induction and growth ( Sang et al, 2001 ; Tao et al, 2016 ).…”

Three-dimensional quantitative assessment of myocardial infarction via multimodality fusion imaging: methodology, validation, and preliminary clinical application

“…The BO method was performed by occluding the middle LAD coronary artery with a temporary balloon for 60 minutes, followed by reperfusion. Conversely, in the BBS embolism group, animal models were constructed using the sequential embolism method as previously reported (19). A sequential embolus gradually and permanently occluded the blood flow distal to the middle segment of LAD.…”